Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: RedShoulder, Steady_T, bennyboy1, kund, grich1, boi568
Search This Board: 
Last Post: 5/14/2021 10:08:40 PM - Followers: 884 - Board type: Free - Posts Today: 134

Anavex Life Sciences Corp (AVXL)

Company website:  http://www.anavex.com/
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA

CIK:  0001314052

Anavex®Life Sciences Corp. (the “Company”) is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer’s disease, other central nervous system (“CNS”) diseases, pain and various types of cancer.  The Company’s lead compound ANAVEX®2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome.

Anavex®Life Sciences’ lead drug candidate, ANAVEX®2-73, recently completed successfully a Phase 2a clinical trial for Alzheimer’s disease.  ANAVEX®2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors.  Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease. It has also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy and others.  The Michael J. Fox Foundation for Parkinson’s Research has awarded Anavex® a research grant to develop ANAVEX®2-73 for the treatment of Parkinson’s disease to fully fund a preclinical study, which could justify moving ANAVEX®2-73 into a Parkinson’s disease clinical trial.  ANAVEX®3-71, also targeting sigma-1 and M1 muscarinic receptors, is a promising preclinical drug candidate demonstrating disease modifications against the major Alzheimer’s hallmarks in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies, and also with beneficial effects on neuroinflammation and mitochondrial dysfunctions.

The Company is in preparation for ANAVEX®2-73 for a Phase 2/3, placebo-controlled trial in Alzheimer’s disease as well as a Phase 2, placebo-controlled trial in Rett syndrome, for which the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for ANAVEX®2-73 and a Phase 2, placebo-controlled trial in Parkinson’s disease.

Headquartered in New York, Anavex® Life Sciences is an American publicly traded corporation on Nasdaq quoted as AVXL

Management:   http://www.anavex.com/about-us/leadership/
Pipeline:  http://www.anavex.com/pipeline/

Patent Info: 

Clinical Trials:  https://clinicaltrials.gov/ct2/results?term=Anavex+Life+Sciences&Search=Search
Recent News:  http://finance.yahoo.com/q?s=avxl&ql=1
Company News Releases:  http://www.anavex.com/2015/?post_type=news
Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=anavex&owner=exclude&action=getcompany
Share Structure:  See SEC filings
Investor Relations:  ir@anavex.com

Marketing Details:  http://convention.bio.org/Printables/Anavex%20Life%20Sciences%20Corp..html


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVXL News: Anavex Life Sciences EPS beats by $0.03 05/13/2021 07:11:29 AM
AVXL News: Anavex Life Sciences Reports Fiscal 2021 Second Quarter Financial Results And Business Outlook 05/13/2021 07:00:00 AM
AVXL News: Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit 05/07/2021 07:00:00 AM
AVXL News: Anavex Life Sciences to Announce Fiscal 2021 Second Quarter Financial Results and Business Outlook on Thursday, May 13, 2021 05/06/2021 07:00:00 AM
AVXL News: Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President for Nonclinical Development 05/05/2021 07:00:00 AM
#300673  Sticky Note 10th Annual SVB Leerink Global Healthcare Conference: MayoMobile 02/25/21 09:09:15 PM
#298434  Sticky Note 2/11/21 Earnings Transcript - archived... XenaLives 02/11/21 10:38:01 PM
#281217  Sticky Note This write-up serves as an overview for Anavex's MayoMobile 11/06/20 01:51:51 PM
#276269  Sticky Note LOL. Why there is zero numerical data in KobeF 10/15/20 03:22:53 PM
#310226   We know that Anavex has a drug distributor Steady_T 05/14/21 10:08:40 PM
#310225   And if there are no SAEs to report Steady_T 05/14/21 08:50:42 PM
#310224   I would expect the full data readout and Kb1123 05/14/21 08:49:32 PM
#310222   Do not want my cousin to get into raja48185 05/14/21 08:17:03 PM
#310221   Full PDD as in everything related to PDD raja48185 05/14/21 08:12:49 PM
#310220   Steady and boi, thank you for your replies. powerwalker 05/14/21 07:46:25 PM
#310219   You don’t think he’s coming out with the Kb1123 05/14/21 07:39:08 PM
#310218   Speaking of trifectas, Midnight Bourbon tomorrow in the powerwalker 05/14/21 06:58:02 PM
#310217   A good day for the stock can make raja48185 05/14/21 06:57:12 PM
#310216   RECRUITED OR ACTUALLY ENROLLED???????? rayovacAAA 05/14/21 06:56:23 PM
#310215   Yessir. Good times ahead for longs! xodcode 05/14/21 06:35:08 PM
#310214   Sounds like it's time to get out the bb8675309 05/14/21 06:28:32 PM
#310213   February 11, 2021 georgejjl 05/14/21 06:27:39 PM
#310212   Lots of eye-poppers...love that. vg_future 05/14/21 06:19:51 PM
#310211   Alz full enrollment before ASM. Little pop. PDD Jonjones325 05/14/21 06:01:06 PM
#310210   Yes Anavex supplies the drug, but presumably not Investor2014 05/14/21 04:55:22 PM
#310209   TGD DOESN'T EVEN KNOW HOW MANY PATIENTS ARE rayovacAAA 05/14/21 04:50:23 PM
#310208   The Q and A related to the post-OLE boi568 05/14/21 04:33:05 PM
#310207   99 cents from breakeven on that $12.07 trade. Investor2014 05/14/21 04:18:25 PM
#310206   It held $11 pretty good on Tuesday too, LBSR TO DA MOON 05/14/21 04:09:47 PM
#310205   Anavex supplies the drug. He should know Doc328 05/14/21 04:03:43 PM
#310204   Cannot believe this thing held 11 today. Jimbo50 05/14/21 04:03:36 PM
#310203   Yes, which is another very good reason SAS Investor2014 05/14/21 04:03:12 PM
#310202   Unlike a study, the reporting of adverse effects Doc328 05/14/21 04:00:13 PM
#310201   AVXL has bounced off of $11 and $11.01 LBSR TO DA MOON 05/14/21 03:31:38 PM
#310199   Thanks ElsaSara. Yes, March 31st DSMB PR stated vg_future 05/14/21 02:12:31 PM
#310198   Based upon the dates and enrollment figures below, LBSR TO DA MOON 05/14/21 02:02:41 PM
#310197   March 31, 92 %. ElsaSara 05/14/21 01:24:42 PM
#310196   It's great to see the $11 level holding LBSR TO DA MOON 05/14/21 01:23:27 PM
#310195   FACTS ABOUT A2-73 P2B/3 TRIAL ENROLLMENT PROGRESS!!!!!!!!!: rayovacAAA 05/14/21 01:23:19 PM
#310194   If I recall correctly, I believe I figured LBSR TO DA MOON 05/14/21 01:18:37 PM
#310193   I think the prior number was 86 percent. boi568 05/14/21 01:16:56 PM
#310192   animal spirits abound. dyp 05/14/21 01:15:43 PM
#310191   What day did we get the update that RedShoulder 05/14/21 12:54:50 PM
#310190   What day did we get the update that LBSR TO DA MOON 05/14/21 12:43:58 PM
#310188   Watch and listen to Dr. Randi J. Hagerman georgejjl 05/14/21 12:31:03 PM
#310187   The FACT that the Anavex Alzheimer's trial is georgejjl 05/14/21 12:28:58 PM
#310186   As posted earlier today, AVXL is currently planning xodcode 05/14/21 12:28:19 PM
#310185   That was a lawsuit over stock promotion, not frrol 05/14/21 12:25:23 PM
#310184   If certainly sounds like that is the plan, frrol 05/14/21 12:19:10 PM
#310183   Just like the last law suit against Anavex Steady_T 05/14/21 12:15:33 PM
#310182   No one would get sued; the company said frrol 05/14/21 12:01:07 PM
#310181   "There is no doubt, expect absolutely GREAT NEWS attilathehunt 05/14/21 11:57:20 AM
#310180   99% non sequitur! Investor2014 05/14/21 11:53:45 AM
#310179   With 1 day left for 13F reporting, so Simonizer 05/14/21 11:49:57 AM
#310178   I agree that Missling is not going to boi568 05/14/21 11:49:26 AM
#310176   The PDD and (US) Rett final full results frrol 05/14/21 11:46:07 AM
#310175   Need income Missling has said that he is Steady_T 05/14/21 11:43:15 AM
#310174   Excellent questions. Hope you get the right answers! abew4me 05/14/21 11:40:22 AM
#310173   There is no doubt, expect absolutely GREAT NEWS georgejjl 05/14/21 11:37:07 AM
Consent Preferences